BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28657872)

  • 1. Desmoid Tumors and Celecoxib with Sorafenib.
    Benech N; Walter T; Saurin JC
    N Engl J Med; 2017 Jun; 376(26):2595-2597. PubMed ID: 28657872
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis.
    Risum S; Bülow S
    Colorectal Dis; 2003 Nov; 5(6):585-6. PubMed ID: 14617246
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases.
    Hamilton L; Blackstein M; Berk T; McLeod RS; Gallinger S; Madlensky L; Cohen Z
    Can J Surg; 1996 Jun; 39(3):247-52. PubMed ID: 8640627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.
    Ezumi K; Yamamoto H; Takemasa I; Nomura M; Ikeda M; Sekimoto M; Monden M
    Jpn J Clin Oncol; 2008 Mar; 38(3):222-6. PubMed ID: 18304951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor.
    Robles J; Keskinyan VS; Thompson M; Davis JT; Mater DV
    Pediatr Hematol Oncol; 2020 Aug; 37(5):445-449. PubMed ID: 32129687
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of an intra-abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis.
    Costa LA; Cezana L; Oliveira TB; Dettino AL; Begnami MD; Pinto CA; Fanelli MF; Mello CA
    Int J Colorectal Dis; 2012 Feb; 27(2):257-9. PubMed ID: 21533592
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
    Gega M; Yanagi H; Yoshikawa R; Noda M; Ikeuchi H; Tsukamoto K; Oshima T; Fujiwara Y; Gondo N; Tamura K; Utsunomiya J; Hashimoto-Tamaoki T; Yamamura T
    J Clin Oncol; 2006 Jan; 24(1):102-5. PubMed ID: 16382119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing.
    Yang S; Wang X; Jiang H; Wang Y; Li Z; Lu H
    Cancer Biol Ther; 2017 Oct; 18(10):757-760. PubMed ID: 28881160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoid tumors respond to chemotherapy: defying the dogma in oncology.
    Patel SR; Benjamin RS
    J Clin Oncol; 2006 Jan; 24(1):11-2. PubMed ID: 16330666
    [No Abstract]   [Full Text] [Related]  

  • 10. Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone.
    Lindor NM; Dozois R; Nelson H; Wolff B; King J; Boardman L; Wilson M; Greene MH; Karnes W; Mesa R; Welch T; Edmonson J; Limburg P
    Am J Gastroenterol; 2003 Aug; 98(8):1868-74. PubMed ID: 12907346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy.
    Tulchinsky H; Keidar A; Strul H; Goldman G; Klausner JM; Rabau M
    Arch Surg; 2005 Feb; 140(2):159-63; discussion 164. PubMed ID: 15723997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case no 4. Aggressive fibromatosis (desmoid tumor) associated with surgically treated familial colonic and duodenal polyposis].
    Tardivon A; Chagnon S
    J Radiol; 2003 Jan; 84(1):71-2. PubMed ID: 12645513
    [No Abstract]   [Full Text] [Related]  

  • 13. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option.
    Sari M
    J Cancer Res Ther; 2020; 16(4):900-902. PubMed ID: 32930137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
    Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
    Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Desmoid tumors associated with familial adenomatous polyposis].
    Makni A; Rebai W; Mizouni H; Fetiriche F; Jouini M; Kacem M; Ben Safta Z
    Tunis Med; 2013 Apr; 91(4):285-6. PubMed ID: 23673714
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review.
    Lynch HT; Fitzgibbons R
    Am J Gastroenterol; 1996 Dec; 91(12):2598-601. PubMed ID: 8946994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib and novel multikinase inhibitors in AML.
    Daver N; Konopleva M
    Lancet Oncol; 2015 Dec; 16(16):1582-3. PubMed ID: 26549588
    [No Abstract]   [Full Text] [Related]  

  • 18. Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.
    Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; Santini D; Cascinu S
    J Urol; 2015 Jan; 193(1):41-7. PubMed ID: 25046616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of a Desmoid Tumor the Developed Around Ileostomy in a Patient with FAP].
    Chika N; Kumamoto K; Suzuki O; Yamamoto A; Tajima Y; Watanabe Y; Onozawa H; Matsuzawa T; Eguchi H; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1947-9. PubMed ID: 26805226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sorafenib in hepatocellular carcinoma.
    Gholam P
    Clin Adv Hematol Oncol; 2015 Apr; 13(4):232-4. PubMed ID: 26352581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.